Prevalence and Survival Patterns of Patients with Bone Metastasis from Common Cancers in Thailand |
Phanphaisarn, Areerak
(Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University)
Patumanond, Jayantorn (Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University) Settakorn, Jongkolnee (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University) Chaiyawat, Parunya (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University) Klangjorhor, Jeerawan (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University) Pruksakorn, Dumnoensun (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University) |
1 | Uchino K, Tateishi R, Shiina S, et al (2011). Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer, 117, 4475-83. DOI |
2 | Zoccali C, Skoch J, Walter CM, et al (2016). The Tokuhashi score: effectiveness and pitfalls. Eur Spine J, 25, 673-8. DOI |
3 | Abbas A, Medvedev S, Shores N, et al (2014). Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci, 59, 2813-20. DOI |
4 | Bae HM, Lee SH, Kim TM, et al (2012). Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer, 77, 572-7. DOI |
5 | Coleman RE (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev, 27, 165-76. DOI |
6 | Coleman RE (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 12, 6243s-9s. DOI |
7 | D'Addario G, Fruh M, Reck M, et al (2010). Metastatic nonsmall-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 116-9. DOI |
8 | Goodwin CR, Abu-Bonsrah N, Boone C, et al (2016). Nonhepatocellular carcinoma spinal metastases. J Clin Neurosci, 27, 22-7. DOI |
9 | Ibrahim T, Mercatali L, Amadori D (2013). A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncol Lett, 6, 306-10. DOI |
10 | Habermehl D, Haase K, Rieken S, et al (2011). Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy. Tumori, 97, 609-13. DOI |
11 | Li S, Peng Y, Weinhandl ED, et al (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol, 4, 87-93. |
12 | Katayose Y, Nakagawa K, Yamamoto K, et al (2012). Lymph nodes metastasis is a risk factor for bone metastasis from extrahepatic cholangiocarcinoma. Hepatogastroenterol, 59, 1758-60. |
13 | Khuntikeo N, Chamadol N, Yongvanit P, et al (2015). Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer, 15, 459. DOI |
14 | Kim SU, Kim DY, Park JY, et al (2008). Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. J Cancer Res Clin Oncol, 134, 1377-84. DOI |
15 | Nguyen DX, Bos PD, Massague J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer, 9, 274-84. DOI |
16 | Liede A, Jerzak KJ, Hernandez RK, et al (2016). The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat, 156, 587-95. DOI |
17 | Makino H, Nishio S, Tsubamoto H, et al (2016). Treatment and prognosis of bone metastasis from cervical cancer (KCOGG1202s). J Obstet Gynaecol Res. |
18 | McDougall JA, Bansal A, Goulart BH, et al (2016). The clinical and economic impacts of skeletal-related events among medicare enrollees with prostate cancer metastatic to bone. Oncologist, 21, 320-6. DOI |
19 | Oster G, Lamerato L, Glass AG, et al (2013). Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer, 21, 3279-86. DOI |
20 | Paholpak P, Sirichativapee W, Wisanuyotin T, et al (2012). Prevalence of known and unknown primary tumor sites in spinal metastasis patients. Open Orthop J, 6, 440-4. DOI |
21 | Tarnoki DL, Tarnoki AD, Ohlmann-Knafo S, et al (2016). Pattern of Tumour Spread of Common Primary Tumours as Seen on Magnetic Resonance Imaging. Pathol Oncol Res, 22, 79-85. DOI |
22 | Qiu ZL, Song HJ, Xu YH, et al (2011). Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab, 96, 3078-86. DOI |
23 | Singh VA, Haseeb A, Alkubaisi AA (2014). Incidence and outcome of bone metastatic disease at University Malaya Medical Centre. Singapore Med J, 55, 539-46. DOI |
24 | Sugino K, Kameyama K, Nagahama M, et al (2014). Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J, 61, 273-9. DOI |
25 | Takagi T, Katagiri H, Kim Y, et al (2015). Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases. PLoS One, 10, 129428. |
26 | Tanaka R, Yonemori K, Hirakawa A, et al (2016). Risk factors for developing skeletal-related events in breast cancer patients with bone metastases undergoing treatment with bone-modifying agents. Oncologist, 21, 508-13. DOI |
27 | Thanapprapasr D, Nartthanarung A, Likittanasombut P, et al (2010). Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer, 20, 373-8. DOI |
28 | Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev, 14, 7029-32. DOI |
29 | Tomita K, Kawahara N, Kobayashi T, et al (2001). Surgical strategy for spinal metastases. Spine, 26, 298-306. DOI |
30 | Tsuya A, Kurata T, Tamura K, et al (2007). Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer, 57, 229-32. DOI |